{
    "startDate": "2018-01-01",
    "endDate": "2018-12-31",
    "year": "2018",
    "quarter": "FY",
    "symbol": "ZYME",
    "data": {
        "bs": [
            {
                "label": "Deferred financing fee.",
                "concept": "zyme:DeferredFinancingFee",
                "unit": "usd",
                "value": 265000
            },
            {
                "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
                "concept": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
                "unit": "usd",
                "value": 18396000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 12016000
            },
            {
                "label": "Prepaid Expense, Noncurrent",
                "concept": "PrepaidExpenseNoncurrent",
                "unit": "usd",
                "value": 1135000
            },
            {
                "label": "Property, Plant and Equipment, Net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 6484000
            },
            {
                "label": "Finite-Lived Intangible Assets, Net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 1614000
            },
            {
                "label": "Deferred Tax Assets, Net, Noncurrent",
                "concept": "DeferredTaxAssetsLiabilitiesNetNoncurrent",
                "unit": "usd",
                "value": 84000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 244363000
            },
            {
                "label": "Cash and Cash Equivalents, at Carrying Value",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 42205000
            },
            {
                "label": "Short-term Investments",
                "concept": "ShortTermInvestments",
                "unit": "usd",
                "value": 157959000
            },
            {
                "label": "The amount of scientific research and experimental development credit receivable as of the balance sheet date.",
                "concept": "zyme:ScientificResearchAndExperimentalDevelopmentCreditReceivable",
                "unit": "usd",
                "value": 997000
            },
            {
                "label": "Accounts Receivable, Net, Current",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 358000
            },
            {
                "label": "Prepaid Expense and Other Assets, Current",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 2850000
            },
            {
                "label": "Assets, Current",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 204369000
            },
            {
                "label": "Deferred Revenue, Noncurrent",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 32941000
            },
            {
                "label": "Liabilities, Other than Long-term Debt, Noncurrent",
                "concept": "LiabilitiesOtherThanLongtermDebtNoncurrent",
                "unit": "usd",
                "value": 946000
            },
            {
                "label": "Liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 63873000
            },
            {
                "label": "Liabilities and Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 244363000
            },
            {
                "label": "Accounts Payable and Accrued Liabilities, Current",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 13403000
            },
            {
                "label": "Derivative Liability, Fair Value, Gross Liability",
                "concept": "DerivativeFairValueOfDerivativeLiability",
                "unit": "usd",
                "value": 12603000
            },
            {
                "label": "Deferred Revenue, Current",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 3530000
            },
            {
                "label": "Other Liabilities, Current",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 450000
            },
            {
                "label": "Liabilities, Current",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 29986000
            },
            {
                "label": "Common Stock, Value, Issued",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 320074000
            },
            {
                "label": "Additional Paid in Capital, Common Stock",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 12347000
            },
            {
                "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -6659000
            },
            {
                "label": "Retained Earnings (Accumulated Deficit)",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -145272000
            },
            {
                "label": "Stockholders' Equity Attributable to Parent",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 180490000
            }
        ],
        "cf": [
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 1880000
            },
            {
                "label": "Amortization of Intangible Assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 1750000
            },
            {
                "label": "Share-based Compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 13441000
            },
            {
                "label": "Deferred Income Tax Expense (Benefit)",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -17000
            },
            {
                "label": "Fair Value Adjustment of Warrants",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 3565000
            },
            {
                "label": "Contingent consideration fair value adjustments.",
                "concept": "zyme:ContingentConsiderationFairValueAdjustments",
                "unit": "usd",
                "value": 237000
            },
            {
                "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": 48000
            },
            {
                "label": "Increase (Decrease) in Accounts Receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 119000
            },
            {
                "label": "Increase (decrease) in the amount of scientific research and experimental development credit receivable.",
                "concept": "zyme:IncreaseDecreaseInAmountOfScientificResearchAndExperimentalDevelopmentCreditReceivable",
                "unit": "usd",
                "value": -1093000
            },
            {
                "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 1344000
            },
            {
                "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 3684000
            },
            {
                "label": "Increase (Decrease) in Contract with Customer, Liability",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 36471000
            },
            {
                "label": "Increase (Decrease) in Income Taxes",
                "concept": "IncreaseDecreaseInIncomeTaxes",
                "unit": "usd",
                "value": 140000
            },
            {
                "label": "Proceeds from Issuance of Common Stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 90752000
            },
            {
                "label": "Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 682000
            },
            {
                "label": "Amount of cash inflow from issuance of shares under share-based compensation arrangement. Issuance includes, but is not limited to, employee share purchase plan.",
                "concept": "zyme:ProceedsFromIssuanceOfSharesUnderEmployeeSharePurchasePlan",
                "unit": "usd",
                "value": 233000
            },
            {
                "label": "The amount of capitalizable costs incurred as part of equity financing transactions that have been paid.",
                "concept": "zyme:PaymentsOfDeferredFinancingFees",
                "unit": "usd",
                "value": 225000
            },
            {
                "label": "Repayments of Long-term Capital Lease Obligations",
                "concept": "RepaymentsOfLongTermCapitalLeaseObligations",
                "unit": "usd",
                "value": 11000
            },
            {
                "label": "Net Cash Provided by (Used in) Financing Activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 91431000
            },
            {
                "label": "Payments for (Proceeds from) Short-term Investments",
                "concept": "PaymentsForProceedsFromShortTermInvestments",
                "unit": "usd",
                "value": 105626000
            },
            {
                "label": "Payments to Acquire Property, Plant, and Equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 803000
            },
            {
                "label": "Payments to Acquire Intangible Assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 2617000
            },
            {
                "label": "Net Cash Provided by (Used in) Investing Activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -109046000
            },
            {
                "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -36556000
            },
            {
                "label": "Net Cash Provided by (Used in) Operating Activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 24177000
            },
            {
                "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": -303000
            },
            {
                "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 6259000
            },
            {
                "label": "The amount of capitalizable costs incurred as part of equity financing transactions that have not been paid.",
                "concept": "zyme:ShareIssueCostsAndDeferredFinancingFeesAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 40000
            },
            {
                "label": "Capital Expenditures Incurred but Not yet Paid",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 382000
            },
            {
                "label": "Cashless exercise of warrants.",
                "concept": "zyme:CashlessExerciseOfWarrants",
                "unit": "usd",
                "value": 4913000
            }
        ],
        "ic": []
    }
}